Atlas Trials

ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer

Clinical trial NCT03294889 · RECRUITING

Trial details

NCT number
NCT03294889
Sponsor
University Hospital, Geneva
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2017-09-01
Primary completion
2022-10-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.